Transforming Technology Infrastructure
Technology is essential in supporting the enormous and growing global OTC derivatives market which had a total notional outstanding of $714.7 trillion at the end of June 2023; 13.1% higher than mid-year 2022 and 15.7% higher compared to year-end 2022. 1
The market has long suffered accusations of opacity and complexity and given the high instances of trading failure - according to data from the Swift network, one in 10 trades fails to settle as planned, while one in 20 trades settles late2 – it may also be criticised for inefficiency.
It is no wonder then that in May 2022 the International Swaps and Derivatives Association (ISDA) published a white paper which set out how market participants should adopt “an ambitious strategy for defining a digital future for financial markets, fostering an environment for technological innovation, and building a safer, more robust global financial system”. 3
This roadmap for digital change in OTC derivatives is, ISDA says, intended to “empower current and future leaders to take proactive steps in developing tangible use cases, resolving challenges associated with these use cases and delivering on the promise of innovative and transformational new technology”.
Over the ensuing year, ISDA reiterated the need for market participants to turn to technology to assist with the increasingly challenging market environment.
In 2023 Scott O’Malia, ISDA Chief Executive Officer, said: “In a highly uncertain economic environment, it would be easy to assume that financial institutions should put technological investments to one side and focus on navigating other pressing challenges. In fact, the reverse is true. With mounting pressure on costs, using technology to create efficiencies can have a positive impact on the bottom lines.” 4
And while ISDA acknowledges the huge number of possible solutions vying for OTC market participants constrained IT budgets, it encourages firms to prioritise exploring distributed ledger technology (DLT); Application Programming Interfaces (APIs); and the Cloud.
Discovering DLT
DLT is projected to be instrumental in improving efficiency in OTC derivative markets, for example delivering $20 billion annually in global clearing and settlement costs by 2030. 5
A survey of 359 financial services companies in 2023 found a 7% increase in the number of firms that are live with DLT and digital asset projects that went live over the year – compared with a 24% jump over 2021 to 2022. 6
However, incorporating DLT is not without its challenges, most significantly in the cost of both implementation and then subsequent maintenance. Firms need to ensure they have a long-term strategy to avoid putting in place a patchwork of solutions that may create more challenges than they solve.
Advancing APIs
Another important technological transformation in the OTC derivatives space comes from APIs, which provide a standardised way for traders, institutions, and developers to access market data, execute trades, and manage their portfolios.
APIs take much of the heavy lifting out of the markets by automating processes; providing a wealth of information including real-time prices and historical data which enables traders and institutions to make informed decisions and develop sophisticated trading strategies.
APIs are also essential in supporting risk management, allowing traders to set stop-loss orders, profit targets, and position limits programmatically. This reduces the potential for disastrous losses and promotes disciplined trading.
The API market is yet to achieve its full potential – further use of AI and machine learning will only serve to improve trading strategies while greater regulation ensures transparency, security, and fair market practices. At the same time, a more connected API landscape will make it even easier to integrate the technology into firms’ existing OTC derivative processes.
Capturing the Cloud
Cloud technology is also transforming the OTC derivatives market, offering participants easy access to derivatives transaction data.
Cloud technology provides firms with real-time access to crucial market data, enabling them to better manage risks associated with trading activities better, and further removing the need for manual data collection.
Parameta Solutions, the data and analytics division of TP ICAP Group, which is the world’s largest inter-broker dealer, has been leading the field in technological transformations for the OTC markets since inception.
Our indicative and transactional data comes with full history for all the markets we cover which is delivered seamlessly into clients' workflows via desktop, cloud, data feed, API solutions and from a range of partners.
This flexibility of delivery empowers market participants with analytical tools and data to fuel algorithms and models, so they can identify trading opportunities and assess risk with ease and within budget.
We are driving the technological transformation of OTC markets, listening to participants and finding solutions that keep our clients ahead of the competition.
To find out more…
Bibliography
[1] ISDA KEY TRENDS IN THE SIZE AND COMPOSITION OF OTC DERIVATIVES MARKETS IN THE FIRST HALF OF 2023 [2] Swift Fewer settlement fails through more visibility [3] ISDA The Future of Derivatives Markets: A Roadmap for Innovation [4] ISDA Continuing Our Digital Journey [5] gfma Impact of Distributed Ledger Technology in Global Capital Markets
[6] Broadridge DLT in the Real World 2023
© 2024 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance.
The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of, any inability to use, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice.
All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.
